The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published in European Heart Journal- Cardiovascular Pharmacotherapy
December 14, 2015 at 20:10 PM EST
The Medicines Company (NASDAQ: MDCO) today announced that the European Heart Journal – Cardiovascular Pharmacotherapy ...